12-80444784-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001145026.2(PTPRQ):c.98C>T(p.Thr33Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0263 in 1,539,526 control chromosomes in the GnomAD database, including 957 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.032 ( 131 hom., cov: 32)
Exomes 𝑓: 0.026 ( 826 hom. )
Consequence
PTPRQ
NM_001145026.2 missense
NM_001145026.2 missense
Scores
1
7
9
Clinical Significance
Conservation
PhyloP100: 4.11
Genes affected
PTPRQ (HGNC:9679): (protein tyrosine phosphatase receptor type Q) This locus encodes a member of the type III receptor-like protein-tyrosine phosphatase family. The encoded protein catalyzes the dephosphorylation of phosphotyrosine and phosphatidylinositol and plays roles in cellular proliferation and differentiation. Mutations at this locus have been linked to autosomal recessive deafness. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0025488138).
BP6
Variant 12-80444784-C-T is Benign according to our data. Variant chr12-80444784-C-T is described in ClinVar as [Benign]. Clinvar id is 508621.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0804 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPRQ | NM_001145026.2 | c.98C>T | p.Thr33Ile | missense_variant | 2/45 | ENST00000644991.3 | NP_001138498.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPRQ | ENST00000644991.3 | c.98C>T | p.Thr33Ile | missense_variant | 2/45 | NM_001145026.2 | ENSP00000495607 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0322 AC: 4885AN: 151738Hom.: 130 Cov.: 32
GnomAD3 genomes
AF:
AC:
4885
AN:
151738
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0456 AC: 6999AN: 153410Hom.: 293 AF XY: 0.0466 AC XY: 3795AN XY: 81408
GnomAD3 exomes
AF:
AC:
6999
AN:
153410
Hom.:
AF XY:
AC XY:
3795
AN XY:
81408
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0256 AC: 35520AN: 1387670Hom.: 826 Cov.: 30 AF XY: 0.0271 AC XY: 18554AN XY: 684630
GnomAD4 exome
AF:
AC:
35520
AN:
1387670
Hom.:
Cov.:
30
AF XY:
AC XY:
18554
AN XY:
684630
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0322 AC: 4894AN: 151856Hom.: 131 Cov.: 32 AF XY: 0.0351 AC XY: 2603AN XY: 74230
GnomAD4 genome
AF:
AC:
4894
AN:
151856
Hom.:
Cov.:
32
AF XY:
AC XY:
2603
AN XY:
74230
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
69
ALSPAC
AF:
AC:
68
ESP6500AA
AF:
AC:
43
ESP6500EA
AF:
AC:
61
ExAC
AF:
AC:
999
Asia WGS
AF:
AC:
209
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 06, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T;.;T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;.;.;.
REVEL
Uncertain
Sift
Uncertain
D;T;D;.;.;.
Sift4G
Pathogenic
D;D;D;D;D;.
Vest4
0.17, 0.57
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at